Cargando…
Long‐term outcomes of combined intravitreal methotrexate and systemic high‐dose methotrexate therapy in vitreoretinal lymphoma
OBJECTIVE: The optimal treatment for vitreoretinal lymphoma (VRL) remains a challenge, as central nervous system (CNS) relapse occurs frequently, leading to the worst impact on survival. We previously proposed combined intravitreal methotrexate and systemic high‐dose methotrexate therapy for this di...
Autores principales: | Cheng, Chieh‐Lung, Yeh, Po‐Ting, Fang, Wei‐Quan, Ma, Wei‐Li, Hou, Hsin‐An, Tsai, Cheng‐Hong, Lin, Chang‐Ping, Tien, Hwei‐Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134364/ https://www.ncbi.nlm.nih.gov/pubmed/36602288 http://dx.doi.org/10.1002/cam4.5609 |
Ejemplares similares
-
Clinical outcomes following intravitreal methotrexate for primary vitreoretinal lymphoma
por: Anthony, Casey L., et al.
Publicado: (2021) -
Retinal changes of primary vitreoretinal lymphoma after intravitreal methotrexate
por: Jiang, Tingting, et al.
Publicado: (2022) -
Reduced frequency of Intravitreal methotrexate injection lowers the risk of Keratopathy in Vitreoretinal lymphoma patients
por: Zhou, Xian, et al.
Publicado: (2020) -
Corneal Epithelial Toxicity after Intravitreal Methotrexate Injection for Vitreoretinal Lymphoma: Clinical and In Vitro Studies
por: Jeong, Yoon, et al.
Publicado: (2020) -
Effect of Intravitreal Methotrexate and Rituximab on Interleukin-10 Levels in Aqueous Humor of Treated Eyes with Vitreoretinal Lymphoma
por: Raja, Harish, et al.
Publicado: (2013)